Roth Capital analyst Matt Koranda initiated coverage of National Vision (EYE) with a Buy rating and $36 price target The firm says new management is driving a successful transformation with new pricing and a focus on attractive managed care customers. This should accelerate National Vision’s core America’s Best and Eyeglass World brands, and drive comp growth, the analyst tells investors in a research note.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EYE:
- National Vision price target raised to $24 from $15 at Wells Fargo
- National Vision upgraded to Overweight from Equal Weight at Barclays
- National Vision Holdings Elects Directors at Annual Meeting
- National Vision price target raised to $26 from $22 at BofA
- Strategic Growth Potential and Competitive Advantage Drive Buy Rating for National Vision Holdings